Cargando…

Strong association of glaucoma with atherosclerosis

Carbonic anhydrases (CAs) catalyze the synthesis of HCO(3)(-) from H(2)O and CO(2.) The dysfunction of CAs leads to aqueous humor secretion and high intraocular pressure to cause glaucoma pathogenesis. Methazolamide (MTZ), a CA inhibitor, can effectively treat glaucoma by reducing aqueous humor secr...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xianqin, Li, Peng, Li, Yunfeng, Yan, Xinfeng, Yuan, Lin, Zhao, Cong, An, Yi, Chang, Xiaotian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062555/
https://www.ncbi.nlm.nih.gov/pubmed/33888852
http://dx.doi.org/10.1038/s41598-021-88322-4
_version_ 1783681791317508096
author Song, Xianqin
Li, Peng
Li, Yunfeng
Yan, Xinfeng
Yuan, Lin
Zhao, Cong
An, Yi
Chang, Xiaotian
author_facet Song, Xianqin
Li, Peng
Li, Yunfeng
Yan, Xinfeng
Yuan, Lin
Zhao, Cong
An, Yi
Chang, Xiaotian
author_sort Song, Xianqin
collection PubMed
description Carbonic anhydrases (CAs) catalyze the synthesis of HCO(3)(-) from H(2)O and CO(2.) The dysfunction of CAs leads to aqueous humor secretion and high intraocular pressure to cause glaucoma pathogenesis. Methazolamide (MTZ), a CA inhibitor, can effectively treat glaucoma by reducing aqueous humor secretion. We previously reported that carbonic anhydrase I (CA1), a CA family member, was highly expressed in atherosclerotic tissues of the aorta and stimulated atherosclerosis (AS) by promoting calcification. MTZ showed therapeutic and preventive effects on AS in a mouse model. The above findings suggest a relationship between AS and glaucoma. This study explored the possible association between AS prevalence and glaucoma prevalence and the therapeutic effect of MTZ on AS by analyzing medical records. Among 10,751 patients with a primary diagnosis of glaucoma, 699 (6.5%) were also diagnosed with AS. However, the incidences of AS in patients with keratitis and scleritis, which are also ophthalmic diseases, were 2.5% (206/8383 patients) and 3.5% (46/1308 patients), respectively. In the population without ophthalmic records, the AS prevalence was only 1.9% (99,416/5,168,481 patients) (all p values between each group were below 0.001). Among 152,425 patients with a primary diagnosis of AS, 1245 (0.82%) were also diagnosed with glaucoma. Among 199,782 patients with a primary diagnosis of hypertension (excluding AS), 1149 (0.57%) were diagnosed with glaucoma, and among 5,313,433 patients without AS or hypertension, 9513 (0.18%) were diagnosed with glaucoma (all p values between each group were below 0.001). Additionally, among 14 patients who suffered from both AS and glaucoma and were treated with MTZ to cure their glaucoma, 9 of them showed reduced low-density lipoprotein (LDL) levels, the main index of AS, within 3 months after medication use (2.81 ± 0.61 mmol/L vs. 2.38 ± 0.58 mmol/L, p = 0.039). The above findings demonstrated a strong relation between AS and glaucoma and suggested that AS patients with glaucoma were more likely to suffer from angle-closure glaucoma.
format Online
Article
Text
id pubmed-8062555
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80625552021-04-23 Strong association of glaucoma with atherosclerosis Song, Xianqin Li, Peng Li, Yunfeng Yan, Xinfeng Yuan, Lin Zhao, Cong An, Yi Chang, Xiaotian Sci Rep Article Carbonic anhydrases (CAs) catalyze the synthesis of HCO(3)(-) from H(2)O and CO(2.) The dysfunction of CAs leads to aqueous humor secretion and high intraocular pressure to cause glaucoma pathogenesis. Methazolamide (MTZ), a CA inhibitor, can effectively treat glaucoma by reducing aqueous humor secretion. We previously reported that carbonic anhydrase I (CA1), a CA family member, was highly expressed in atherosclerotic tissues of the aorta and stimulated atherosclerosis (AS) by promoting calcification. MTZ showed therapeutic and preventive effects on AS in a mouse model. The above findings suggest a relationship between AS and glaucoma. This study explored the possible association between AS prevalence and glaucoma prevalence and the therapeutic effect of MTZ on AS by analyzing medical records. Among 10,751 patients with a primary diagnosis of glaucoma, 699 (6.5%) were also diagnosed with AS. However, the incidences of AS in patients with keratitis and scleritis, which are also ophthalmic diseases, were 2.5% (206/8383 patients) and 3.5% (46/1308 patients), respectively. In the population without ophthalmic records, the AS prevalence was only 1.9% (99,416/5,168,481 patients) (all p values between each group were below 0.001). Among 152,425 patients with a primary diagnosis of AS, 1245 (0.82%) were also diagnosed with glaucoma. Among 199,782 patients with a primary diagnosis of hypertension (excluding AS), 1149 (0.57%) were diagnosed with glaucoma, and among 5,313,433 patients without AS or hypertension, 9513 (0.18%) were diagnosed with glaucoma (all p values between each group were below 0.001). Additionally, among 14 patients who suffered from both AS and glaucoma and were treated with MTZ to cure their glaucoma, 9 of them showed reduced low-density lipoprotein (LDL) levels, the main index of AS, within 3 months after medication use (2.81 ± 0.61 mmol/L vs. 2.38 ± 0.58 mmol/L, p = 0.039). The above findings demonstrated a strong relation between AS and glaucoma and suggested that AS patients with glaucoma were more likely to suffer from angle-closure glaucoma. Nature Publishing Group UK 2021-04-22 /pmc/articles/PMC8062555/ /pubmed/33888852 http://dx.doi.org/10.1038/s41598-021-88322-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Song, Xianqin
Li, Peng
Li, Yunfeng
Yan, Xinfeng
Yuan, Lin
Zhao, Cong
An, Yi
Chang, Xiaotian
Strong association of glaucoma with atherosclerosis
title Strong association of glaucoma with atherosclerosis
title_full Strong association of glaucoma with atherosclerosis
title_fullStr Strong association of glaucoma with atherosclerosis
title_full_unstemmed Strong association of glaucoma with atherosclerosis
title_short Strong association of glaucoma with atherosclerosis
title_sort strong association of glaucoma with atherosclerosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062555/
https://www.ncbi.nlm.nih.gov/pubmed/33888852
http://dx.doi.org/10.1038/s41598-021-88322-4
work_keys_str_mv AT songxianqin strongassociationofglaucomawithatherosclerosis
AT lipeng strongassociationofglaucomawithatherosclerosis
AT liyunfeng strongassociationofglaucomawithatherosclerosis
AT yanxinfeng strongassociationofglaucomawithatherosclerosis
AT yuanlin strongassociationofglaucomawithatherosclerosis
AT zhaocong strongassociationofglaucomawithatherosclerosis
AT anyi strongassociationofglaucomawithatherosclerosis
AT changxiaotian strongassociationofglaucomawithatherosclerosis